A joint governance framework for PET-CT to achieve standardised care pathways

March 2016

Share to Twitter Share to Facebook Share to LinkedIn Send by email

In a unique collaboration between the NHS and the independent sector, 60% of PET-CT services across England are being aligned into a single governance framework as part of an initiative to achieve clinical excellence through standardised service delivery.

The collaborative partnership between The Christie NHS Foundation Trust (the largest cancer centre in Europe) and Alliance Medical brings together other NHS hospitals, patient representatives, academic centres, charities and commissioners to deliver PET-CT services under the new National Contract.   

These groups have joined together as the Molecular Imaging Collaborative Network (MICN) and at its heart is a Governance Committee, set up to determine and ensure standardised clinical practices across all sites, to follow the Intercollegiate College evidence-based indications for PET-CT.

The Governance Committee is chaired by leading independent clinicians and represented by clinicians from the 31 NHS Trusts involved in the PET-CT network, institutions, The Christie, patient representatives and Alliance Medical. The involvement of local Governance Boards ensures that patient needs are fully reflected across England.

The Alliance Medical Molecular Governance Committee (AMMIGC) is setting the direction of service development and also determines education and training research needs, working with the Clinical Research Group (CRG) to evaluate and collect an evidence base for PET-CT.  Examples of research projects include dose reduction programmes, radiotherapy planning using PET-CT and monitoring treatment response.  As well as guiding clinical decisions, the information collected will support decision-making by commissioners.

An award-winning partnership

This award is a great achievement for Alliance Medical and The Christie which recognises the clinically-led and collaborative approach of the MICN as an innovative solution to delivering a world-class PET-CT service. 

The MICN partnership has a shared purpose of improving overall cancer survival rates above the current 54% by 2025 and has been widely acknowledged as an exemplar of how the independent sector supports the future of the NHS.

In November 2015, the partnership was awarded ‘Public-Private Partnership’ at the Laing and Buisson Healthcare Awards. 

It is a great achievement which recognises the innovative solution and network that will deliver a world class PET-CT service delivered to patients through our clinically-led and collaborative approach.
Charles Niehaus
CMO/COO at Alliance Medical

To discuss your own specific imaging needs, please contact us.


Read more of our partnership case studies

AML Quality Account 2020/21

The report has now been finalised and is ready for download


View profiles of our UK Board and Management Team

Our story

Learn more about our history and growth


Corporate governance and quality assured service excellence

Alliance Medical are Europe’s leading independent provider of medical imaging services. 

We combine service excellence and innovative imaging technologies to improve patient care and support NHS and independent sector organisations with their ongoing imaging requirements. Our approach has delivered consistent company growth for more than 25 years.


Close menu

Current vacancies

Visit our jobs site to view latest vacancies, register as a candidate and apply for jobs.

Search vacancies now

Carrying out over 2 million scans per year, we set our standards high when it comes to our people and their careers. Investment in integrated systems and individual expertise allows the development of services and long term partnerships to be forged which has seen us grow to be the imaging healthcare provider of choice for patients, referrers and employees.
Quality, safety and transparency underpin all the we do.
Close menu

Alliance Medical is Europe’s leading diagnostic and molecular imaging services provider delivering high quality diagnostic solutions in partnership with public organisations.  

We form an effective part of the health economy in each of the countries in which we operate and see our role as supporting the existing healthcare infrastructure, providing innovative partnership solutions to address local challenges in a way that builds on the strengths of existing core services.

Close menu